Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 8, 2019 (7 years ago)

StellaLife VEGA Oral Gel Rinse

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

StellaLife VEGA Oral Gel Rinse (In equal parts of: Azadirachta Indica 1x, Calendula Officinalis 1x, Echinacea Purpurea 1x, Plantago Major 1x), packaged in 1000 mL white plastic bottle.

Drug: Calendula

Recalling firm
Washington Homeopathic Products, Inc.
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0505-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Calendula recalls

See all
Class II · Moderate risk

Menastil

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. NDC 66233-711-01 D-0084-2023
Class II · Moderate risk

ProSirona

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. NDC 66233-712-01 D-0083-2023
Class II · Moderate risk

Neuroquell

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. D-0082-2023
Class II · Moderate risk

Neuroquell Plus

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. D-0081-2023
Class III · Low risk

Calendula Cream

Labeling: Labeling Error on Declared Strength; The outer carton (secondary packaging) statement of ingredients misstates the concentration of active ingredient at 7%. The primary packaging (tube) correctly states the active ingredient at 10%.

Terminated Labeling / mix-up Boiron Inc. D-0803-2018

Other recalls by Washington Homeopathic Products, Inc.

All 2019 recalls
Class III · Low risk

Complete 30C/200C Homeopathic Kit

Labeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.

Terminated Labeling / mix-up Washington Homeopathic Products, Inc. D-0618-2024
Class II · Moderate risk

Vaccinotoxinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1141-2022
Class II · Moderate risk

Tuberculinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1139-2022